ABL Bio Inc. (KOSDAQ:298380)
139,400
-33,300 (-19.28%)
Apr 28, 2026, 3:30 PM KST
102.03% (1Y)
| Market Cap | 7.80T |
| Revenue (ttm) | 79.35B |
| Net Income (ttm) | -37.81B |
| Shares Out | 55.99M |
| EPS (ttm) | -734.08 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 2,924,760 |
| Average Volume | 568,463 |
| Open | 144,900 |
| Previous Close | 172,700 |
| Day's Range | 131,900 - 145,200 |
| 52-Week Range | 57,700 - 257,500 |
| Beta | 0.60 |
| RSI | 37.60 |
| Earnings Date | May 13, 2026 |